Journal Bias: Novelty Preferred (which Can Be Bad) / Science News

Journal Bias: Novelty Preferred (which Can Be Bad) / Science News

FDA Clears a Test for Ovarian Cancer | Reuters

FDA Clears a Test for Ovarian Cancer | Reuters: "OVA1 should be used by primary care physicians or gynecologists as an adjunctive test to complement, not replace, other diagnostic and clinical procedures. OVA1 uses a blood sample to test for levels of five proteins that change due to ovarian cancer. The test combines the five separate results into a single numerical score between 0 and 10 to indicate the likelihood that the pelvic mass is benign or malignant. OVA1 is intended only for women, 18 years and older, who are already selected for surgery because of their pelvic mass. It is not intended for ovarian cancer screening or for a definitive diagnosis of ovarian cancer. Interpreting the test result requires knowledge of whether the woman is pre- or post-menopausal."

U.S. Yondelis - FDA delays decision on J&J ovarian cancer drug - Forbes.com

Clinical Care Options Oncology - Ovarian Cancer—Recent Developments in the Standard of Care and Emerging Options

Clinical Care Options Oncology - Ovarian Cancer—Recent Developments in the Standard of Care and Emerging Options: "Virtual Presentations
I. Frontline Management—IP and Maintenance Therapy
II. Rising CA-125: To Treat or Not to Treat?"

Does Cancer Make You Strong? - Well Blog - NYTimes.com

Does Cancer Make You Strong? - Well Blog - NYTimes.com

Social Networking and Healthcare

Patient choice and evidence based decisions: The case of complementary therapies

FDA panel urges HPV vaccine be given to boys - CNN.com

Patient Modesty and Selection of Healthcare Provider Gender - Medpedia

Patient Modesty and Selection of Healthcare Provider Gender - Medpedia

Health biotech firms with developing country partners better postitioned to innovate, prosper

Health biotech firms with developing country partners better postitioned to innovate, prosper

ASCO: Poor Outcome with Doctor-Patient Disconnect - Advanced cancer patients at greater risk of death if there is a gap in self-assessed, physician-assessed performance status - Modern Medicine

ASCO: Poor Outcome with Doctor-Patient Disconnect - Advanced cancer patients at greater risk of death if there is a gap in self-assessed, physician-assessed performance status - Modern Medicine

ACOG: Lawsuits Can Result from Poor Communication - Full disclosure of medical errors is key in reducing malpractice claims, expert argues - Modern Medicine

ACOG: Lawsuits Can Result from Poor Communication - Full disclosure of medical errors is key in reducing malpractice claims, expert argues - Modern Medicine

Gender Inequity Observed in Hematuria Referral - Men are more likely to be referred for urological evaluation than women - Modern Medicine

Gender Inequity Observed in Hematuria Referral - Men are more likely to be referred for urological evaluation than women - Modern Medicine

Treatment of recurrent epithelial ovarian cancer - open text publisher/review

Treatment of recurrent epithelial ovarian cancer - Dove Press

JAMA -- Abstract: Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials, September 2, 2009, Mathieu et al. 302 (9): 977

JAMA -- Abstract: Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials, September 2, 2009, Mathieu et al. 302 (9): 977

Vital Signs - Awareness - Clinical Trial Rule Is Widely Ignored - NYTimes.com

Vital Signs - Awareness - Clinical Trial Rule Is Widely Ignored - NYTimes.com

A Conversation about Personal Genomic Tests with Dr. Muin Khoury

In Cancer, Hitting a Target Called Hedgehog

Finding the Right Mix of Care Providers for Cancer Patients

Distribution and determinants of patient satisfaction in oncology: A r

Efficacy, Safety, and Tolerability of Low-Dose Hormone Therapy in Managing Menopausal Symptoms

Efficacy, Safety, and Tolerability of Low-Dose Hormone Therapy in Managing Menopausal Symptoms -- Langer 22 (5): 563 -- The Journal of the American Board of Family Medicine

Expanded extracolonic tumor spectrum in MUTYH-associated polyposis

An Internet Tool for Creation of Cancer Survivorship Care Plans for Survivors and Health Care Providers: Design, Implementation, Use and User Satisfac

Response Letter: Anxiety and depression among long-term survivors of cancer in Australia: results of a population-based survey

Further, the authors’ assertion that psychosocial wellbeing several years after cancer diagnosis is comparable with that of the general population cannot be substantiated by studies conducted by this method.

eMJA: Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications?

eMJA: Adequacy of consent documentation in a specialty surgical unit: time for community debate?

Person of the Week: UNC Dr. Band - Two gynecologic oncology surgeons from UNC Women's Hospital are preparing for a big debut. They landed a record deal and are about to release their first album. - 9/04/09 - Raleigh News - abc11.com

Person of the Week: UNC Dr. Band - Two gynecologic oncology surgeons from UNC Women's Hospital are preparing for a big debut. They landed a record deal and are about to release their first album. - 9/04/09 - Raleigh News - abc11.com

Time costs associated with informal caregiving for...[Cancer. 2009] - PubMed Result

Informal caregiver time costs over the 2-year period after diagnosis were the highest for caregivers of patients diagnosed with lung ..... and ovarian.

Incomplete pregnancy and risk of ovarian cancer: results from two Australian case-control studies and systematic review

Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England

No association between a candidate TCF7L2 variant and risk of breast or ovariancancer

Circulating vitamin d and risk of epithelial ovarian cancer

The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy

Cancer risk perception on the basis of individuals at risk for Lynch Syndrome

Weigh in on cancer research spending in Canada

Weigh in on cancer research spending in Canada

Current Status of Palliative Care--Clinical Implementation, Education, and Research -- Grant et al. 59 (5): 327 -- CA: A Cancer Journal for Clinicians

Medicine 2.0 2009 conference Toronto Sept 17-18th

Tamoxifen versus Aromatase Inhibitors for Breast Cancer Prevention -- Yue et al. 11 (2): 925s -- Clinical Cancer Research

Estrogen, Estrogen Plus Progestin Therapy, and Risk of Breast Cancer -- Colditz 11 (2): 909s -- Clinical Cancer Research

Expanded extracolonic tumor spectrum in MUTYH-associated polyposis

Patterns of care and survival in cancer patients with cognitive impairment

Ovarian Cancer Montage - new faces, new music

End of Life, year after year after year (a must read article)

Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there yet?

dentification of a Novel Pathogenic Mutation in BRCA 2 in a Spanish Breast-Ovarian Cancer Family

Endometriosis and ovarian cancer: A review

Association of a Cancer Diagnosis With Vulnerability and Frailty in Older Medicare Beneficiaries -- Mohile et al. 101 (17): 1206 -- JNCI Journal of the National Cancer Institute

Association of a Cancer Diagnosis With Vulnerability and Frailty in Older Medicare Beneficiaries -- Mohile et al. 101 (17): 1206 -- JNCI Journal of the National Cancer Institute

Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study

Centralization of Cancer Surgery: Implications for Patient Access to Optimal Care -- Stitzenberg et al., 10.1200/JCO.2008.20.1715 -- Journal of Clinical Oncology

Centralization of Cancer Surgery: Implications for Patient Access to Optimal Care -- Stitzenberg et al., 10.1200/JCO.2008.20.1715 -- Journal of Clinical Oncology

Health News Review Publisher's Note

Health News Review Publisher's Note